biden glp-1 Trump officials plan coverage for weight loss drugs under Medicare and Medicaid | Trump administration Medicare Will Not Cover GLP-1

Research Benefits BPC-157 ARG and Blood Vessel Growth One of the notable research benefits of BPC-157 ARG is its potential role in promoting blood vessel growth

Tang, D., Chen, K., Huang, L

Reported benefits include enhanced glycemic control, weight reduction, and decreased levels of inflammatory markers, suggesting that GLP-1 RAs may modulate immune pathways and proinflammatory cytokine activity involved in the pathogenesis of psoriasis

In November 2023, a new GLP-1, called tirzepatide (Zepbound, Mounjaro), was approved for weight loss and obesity management

Guo J, Chaney KE, Choi K, Witek G, Patel AV, Xie H, et al